Evotec Climbs to Highest in 15 Years on Sanofi Milestone
Alert: HALISTER1
Source: BFW (Bloomberg First Word)
Tickers
SAN FP (Sanofi)
EVT GR (Evotec AG)
People
Igor Kim (Oddo & Cie SCA)
Topics
Top Midcap Coverage
To de-activate this alert, click here
To modify this alert, click here
UUID: 7947283
(Bloomberg) -- Evotec shares rose as much as 5.2% to highest since 2002 after co. said a strategic alliance with Sanofi on diabetes research reached an “important” milestone.
- Shares trade at EU9.771, up 3.4%, as of 11:23am local time
- Stock up for 8th consecutive day, longest streak since Sept.
- Milestone marks the first positive results from diabetes alliance with Sanofi, Igor Kim, a healthcare and biotech analyst at Oddo & Cie., writes in client note
- Novel therapeutic approaches based on restoring beta- cell mass can potential reduce or eliminate need for insulin injections: Kim
- Says milestone payments already considered in brokerage’s prognosis, estimates unchanged
- NOTE: Evotec Achieves First Milestone in Diabetes Alliance With Sanofi
- Evotec up 3.1% at 11:51am vs 0.2% drop in TDXP
Alert: HALISTER1
Source: BFW (Bloomberg First Word)
Tickers
SAN FP (Sanofi)
EVT GR (Evotec AG)
People
Igor Kim (Oddo & Cie SCA)
Topics
Top Midcap Coverage
To de-activate this alert, click here
To modify this alert, click here
UUID: 7947283